Test Code HIAA 5-Hydroxyindoleacetic Acid, 24 Hour, Urine
Reporting Name
5-Hydroxyindoleacetic Acid, UUseful For
Biochemical diagnosis and monitoring of intestinal carcinoid syndrome using 24-hour urine specimens
Performing Laboratory
 Mayo Clinic Laboratories in Rochester
Specimen Type
UrineOrdering Guidance
This test is the preferred test for measurement of 5-hydroxyindoleacetic acid concentrations. If a random urine collection is preferred, order HIAAR / 5-Hydroxyindoleacetic Acid, Random, Urine.
Necessary Information
1. Collection duration and urine volume in milliliters are required.
2. Patient's age and sex are required.
Specimen Required
Patient Preparation:
1. Some medications could interfere with test results. If medically feasible, for 48 hours before specimen collection, patient should not take the following medications:
-Acetaminophen (Tylenol or generic versions)
-Tryptophan containing supplements
2. For 48 hours prior to, as well as during, the urine collection, the patient should limit the following to one serving per day:
-Fruits
-Vegetables
-Nuts
-Caffeinated beverages or foods
Supplies: Urine Tubes, 10 mL (T068)
Container/Tube: Plastic, 10-mL urine tube
Specimen Volume: 5 mL
Collection Instructions:
1. Add 25 mL of 50% acetic acid as preservative at start of collection. Use 15 mL of 50% acetic acid for children younger than 5 years.
2. Collect a 24-hour urine specimen.
Additional Information: See Urine Preservatives-Collection and Transportation for 24-Hour Urine Specimens for multiple collections.
Specimen Minimum Volume
1 mL
Specimen Stability Information
| Specimen Type | Temperature | Time | 
|---|---|---|
| Urine | Refrigerated (preferred) | 56 days | 
| Frozen | 365 days | 
Special Instructions
Reference Values
| 
 5-HIAA, mg/24 hour 99th percentile cutoff  | 
||
| 
 Age  | 
 Female  | 
 Male  | 
| 
 ≤23 months  | 
 ≤2.7  | 
 ≤2.3  | 
| 
 24-35 months  | 
 ≤3.0  | 
 ≤2.6  | 
| 
 3 years  | 
 ≤3.2  | 
 ≤2.9  | 
| 
 4 years  | 
 ≤3.4  | 
 ≤3.2  | 
| 
 5 years  | 
 ≤3.6  | 
 ≤3.6  | 
| 
 6 years  | 
 ≤3.8  | 
 ≤3.9  | 
| 
 7 years  | 
 ≤4.0  | 
 ≤4.2  | 
| 
 8 years  | 
 ≤4.2  | 
 ≤4.5  | 
| 
 9 years  | 
 ≤4.5  | 
 ≤4.8  | 
| 
 10 years  | 
 ≤4.7  | 
 ≤5.1  | 
| 
 11 years  | 
 ≤4.9  | 
 ≤5.3  | 
| 
 12 years  | 
 ≤5.2  | 
 ≤5.6  | 
| 
 13 years  | 
 ≤5.4  | 
 ≤5.8  | 
| 
 14 years  | 
 ≤5.6  | 
 ≤6.1  | 
| 
 15 years  | 
 ≤5.7  | 
 ≤6.3  | 
| 
 16 years  | 
 ≤5.9  | 
 ≤6.4  | 
| 
 17 years  | 
 ≤6.0  | 
 ≤6.6  | 
| 
 18 years  | 
 ≤6.0  | 
 ≤6.7  | 
| 
 19 years  | 
 ≤6.1  | 
 ≤6.8  | 
| 
 20 years  | 
 ≤6.1  | 
 ≤6.9  | 
| 
 21 years  | 
 ≤6.2  | 
 ≤6.9  | 
| 
 22 years  | 
 ≤6.2  | 
 ≤7.0  | 
| 
 23 years  | 
 ≤6.2  | 
 ≤7.0  | 
| 
 24 years  | 
 ≤6.3  | 
 ≤7.1  | 
| 
 25 years  | 
 ≤6.3  | 
 ≤7.2  | 
| 
 26 years  | 
 ≤6.3  | 
 ≤7.2  | 
| 
 27 years  | 
 ≤6.4  | 
 ≤7.3  | 
| 
 28 years  | 
 ≤6.4  | 
 ≤7.4  | 
| 
 29 years  | 
 ≤6.5  | 
 ≤7.5  | 
| 
 30 years  | 
 ≤6.6  | 
 ≤7.5  | 
| 
 31 years  | 
 ≤6.6  | 
 ≤7.6  | 
| 
 32 years  | 
 ≤6.7  | 
 ≤7.7  | 
| 
 33 years  | 
 ≤6.8  | 
 ≤7.7  | 
| 
 34 years  | 
 ≤6.8  | 
 ≤7.8  | 
| 
 35 years  | 
 ≤6.9  | 
 ≤7.9  | 
| 
 36 years  | 
 ≤6.9  | 
 ≤7.9  | 
| 
 37 years  | 
 ≤7.0  | 
 ≤8.0  | 
| 
 38 years  | 
 ≤7.0  | 
 ≤8.1  | 
| 
 39 years  | 
 ≤7.0  | 
 ≤8.2  | 
| 
 40 years  | 
 ≤7.1  | 
 ≤8.2  | 
| 
 41 years  | 
 ≤7.1  | 
 ≤8.3  | 
| 
 42 years  | 
 ≤7.2  | 
 ≤8.4  | 
| 
 43 years  | 
 ≤7.3  | 
 ≤8.5  | 
| 
 44 years  | 
 ≤7.4  | 
 ≤8.6  | 
| 
 45 years  | 
 ≤7.4  | 
 ≤8.7  | 
| 
 46 years  | 
 ≤7.5  | 
 ≤8.8  | 
| 
 47 years  | 
 ≤7.6  | 
 ≤8.9  | 
| 
 48 years  | 
 ≤7.6  | 
 ≤9.0  | 
| 
 49 years  | 
 ≤7.7  | 
 ≤9.1  | 
| 
 50 years  | 
 ≤7.7  | 
 ≤9.2  | 
| 
 51 years  | 
 ≤7.8  | 
 ≤9.3  | 
| 
 52 years  | 
 ≤7.8  | 
 ≤9.4  | 
| 
 53 years  | 
 ≤7.9  | 
 ≤9.5  | 
| 
 54 years  | 
 ≤8.0  | 
 ≤9.6  | 
| 
 55 years  | 
 ≤8.1  | 
 ≤9.7  | 
| 
 56 years  | 
 ≤8.1  | 
 ≤9.7  | 
| 
 57 years  | 
 ≤8.2  | 
 ≤9.8  | 
| 
 58 years  | 
 ≤8.3  | 
 ≤9.8  | 
| 
 59 years  | 
 ≤8.3  | 
 ≤9.8  | 
| 
 60 years  | 
 ≤8.3  | 
 ≤9.9  | 
| 
 61 years  | 
 ≤8.3  | 
 ≤9.9  | 
| 
 62 years  | 
 ≤8.4  | 
 ≤9.9  | 
| 
 63 years  | 
 ≤8.4  | 
 ≤10.0  | 
| 
 64 years  | 
 ≤8.4  | 
 ≤10.0  | 
| 
 65 years  | 
 ≤8.4  | 
 ≤10.0  | 
| 
 66 years  | 
 ≤8.5  | 
 ≤10.1  | 
| 
 67 years  | 
 ≤8.5  | 
 ≤10.1  | 
| 
 68 years  | 
 ≤8.5  | 
 ≤10.1  | 
| 
 69 years  | 
 ≤8.5  | 
 ≤10.2  | 
| 
 70 years  | 
 ≤8.5  | 
 ≤10.2  | 
| 
 71 years  | 
 ≤8.6  | 
 ≤10.2  | 
| 
 72 years  | 
 ≤8.6  | 
 ≤10.2  | 
| 
 73 years  | 
 ≤8.5  | 
 ≤10.1  | 
| 
 74 years  | 
 ≤8.5  | 
 ≤10.1  | 
| 
 75 years  | 
 ≤8.6  | 
 ≤10.1  | 
| 
 76 years  | 
 ≤8.6  | 
 ≤10.0  | 
| 
 77 years  | 
 ≤8.6  | 
 ≤10.0  | 
| 
 78 years  | 
 ≤8.6  | 
 ≤10.0  | 
| 
 79 years  | 
 ≤8.6  | 
 ≤10.0  | 
| 
 80 years  | 
 ≤8.7  | 
 ≤9.9  | 
| 
 81 years  | 
 ≤8.7  | 
 ≤9.9  | 
| 
 82 years  | 
 ≤8.7  | 
 ≤9.9  | 
| 
 83 years  | 
 ≤8.7  | 
 ≤9.9  | 
| 
 84 years  | 
 ≤8.7  | 
 ≤9.9  | 
| 
 85 years  | 
 ≤8.6  | 
 ≤9.8  | 
| 
 86 years  | 
 ≤8.5  | 
 ≤9.8  | 
| 
 87 years  | 
 ≤8.4  | 
 ≤9.7  | 
| 
 88 years  | 
 ≤8.3  | 
 ≤9.7  | 
| 
 89 years  | 
 ≤8.1  | 
 ≤9.5  | 
| 
 90 years  | 
 ≤7.9  | 
 ≤9.4  | 
| 
 91 years  | 
 ≤7.6  | 
 ≤9.2  | 
| 
 92 years  | 
 ≤7.4  | 
 ≤9.0  | 
| 
 93 years  | 
 ≤7.1  | 
 ≤8.8  | 
| 
 94 years  | 
 ≤7.0  | 
 ≤8.7  | 
| 
 = 95 years  | 
 ≤6.9  | 
 ≤8.6  | 
For SI unit Reference Values, see www.mayocliniclabs.com/order-tests/si-unit-conversion.html
Day(s) Performed
Monday through Friday
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
83497
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value | 
|---|---|---|
| HIAA | 5-Hydroxyindoleacetic Acid, U | 1695-6 | 
| Result ID | Test Result Name | Result LOINC Value | 
|---|---|---|
| 9248 | 5-Hydroxyindoleacetic Acid, U | 1695-6 | 
| TM35 | Collection Duration | 13362-9 | 
| VL33 | Urine Volume | 3167-4 | 
Clinical Information
5-Hydroxyindoleacetic acid (5-HIAA) is the major metabolite of serotonin and is excreted in the urine. Intestinal carcinoid tumors, along with neuroendocrine tumors, can produce excess amounts of 5-HIAA and serotonin, especially in individuals with carcinoid syndrome. Carcinoid syndrome is characterized by carcinoid tumors, flushing, heart disease, and hepatomegaly.
Measurement of 5-HIAA in a 24-hour urine specimen can diagnose carcinoid disease with a high specificity.
Interpretation
If pharmacological and dietary artifacts have been ruled out, an elevated excretion of 5-hydroxyindoleacetic acid is a probable indicator of the presence of a serotonin-producing tumor.
Report Available
2 to 4 daysSpecimen Retention Time
7 daysMethod Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Forms
If not ordering electronically, complete, print, and send an Oncology Test Request (T729) with the specimen.